Sunden-Cullberg J, Chen P, Habel H, Skorup P, et al. Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial. PLoS One 2023;18:e0295838.
PMID: 38157348